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Madrid, Madrid, Spain; 3The OT Practice, Hook, Hampshire, UKA B S T R A C TBackground: Education leads to better health-related decisions and
protective behaviors, being especially important for patients with
chronic conditions. Self-management education programs have been
shown to be beneﬁcial for patients with different chronic conditions
and to have a higher impact on health outcomes than does didactic
education. Objective: To investigate improvements in glycemic con-
trol (measured by glycated hemoglobin A1c) in patients with type 2
diabetes mellitus. Methods: Our comparative trial involved one group
of patients receiving patient-centered education and another receiv-
ing didactic education. We dealt with selection bias issues, estimated
the different impact of both programs, and validated our analysis
using quantile regression techniques. Results: We found evidence of
better mean glycemic control in patients receiving the patient-
centered program, which engaged better patients. Nevertheless,
that differential impact is nonmonotonic. Patients initially at
the healthy range at the patient-centered program maintained
their condition better. Patients close to, but not within, the healthy
range beneﬁted equally from attending either program. Patientsee front matter Copyright & 2016, International S
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23 Pozuelo de Alarcón, Madrid, Spain.with very high glycemic level beneﬁted signiﬁcantly more from
attending the patient-centered program. Finally, patients with
the worst initial glycemic control (far from the healthy range)
improved equally their diabetic condition, regardless of which
program they attended. Conclusions: Different patients are sensi-
tive to different categories of education programs. The optimal,
cost-effective design of preventative programs for patients with
chronic conditions needs to account for the different impact in
different “patient categories.” This implies stratifying patients and
providing the appropriate preventative education program, or
looking for alternative policy implementations for unresponsive
patients who have the most severe condition and are the most
costly.
Keywords: chronic disease self-management, patient-centered education,
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Education is a key input in the health production function [1]. It
leads individuals to take better health-related decisions and
develop improved preventative behavior in terms of diet, exer-
cise, and lifestyle, both for themselves [2–5] and for their children
[6,7]. Empirical studies identify strong correlations between
education background and health status [8–10] and between
income levels and health status [11,12]. Education is especially
important for patients with chronic conditions or individuals at
risk of developing chronic conditions; they suffer (or are at risk of
suffering) from long-lasting conditions with persistent effects [13]
that progressively diminish their quality of life, functional status,and productivity [14,15]. Therefore, it is important for patients
with chronic conditions to learn how to live with their conditions,
or for individuals at risk to prevent them. Moreover, the way in
which chronic conditions are prevented and treated is of public
concern because at present these account for more than 70%
of health expenditures [16,17], are estimated to account for 70% of
the global disease burden, and will be responsible for 80% of
deaths across the world by 2030 [18,19].
Patient self-management education programs have been
shown to be beneﬁcial for patients with different chronic con-
ditions, such as asthma [20], cardiac disease [21], chronic obstruc-
tive pulmonary disease [22], and type 2 diabetes [23–27]. They
have the potential to make patients’ lifestyle healthier, improveociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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services provision and their health expenditures.
In this article, we focus on education programs for patients
with diabetes mellitus (type 2 diabetes). Diabetes mellitus is a
chronic disease in which the body fails to create, release, and/or
respond to insulin, resulting in hyperglycemia (raised blood sugar
levels) and systemic damage to many areas of the body, including
the circulatory system, the nervous system, and internal organs.
It is a major cause of morbidity and mortality, estimated to
globally affect 9% adults 18 years and older [28]. Diabetes is
responsible for enormous individual health costs related to direct
and indirect effects of hyperglycemia on the human vascular
tree. Its impact on patients’ life expectancy and health-related
quality of life depends on the severity and duration of hyper-
glycemia, that is, the extent by which a person’s glycated
hemoglobin A1c (HbA1c) blood sugar levels lie outside the healthy
range (4.0–7.0 mmol/L) and the length of time for which this
occurs. In fact, the largest prospective, randomized study to date
involving patients with type 2 diabetes (UK Prospective Diabetes
Study [UKPDS 35]) [29] estimated that each 1% reduction in HbA1c
level reduces the risk of deaths related to diabetes by 21%,
myocardial infarction by 14%, and microvascular complications
by 37%. Other studies with data from the United States [30–32]
relate better glycemic control with fewer complications, hospital
admissions, and lower health expenditures.
Diabetes is a largely “self-managed” condition. Day-to-day
management is overwhelmingly in the hands of the patient, who
must make long-term healthy lifestyle changes involving diet,
exercise, and medication. Consequently, the quality of the diabetes
education that patients receive shortly after initial diagnosis
signiﬁcantly inﬂuences their health choices, promoting diet,
exercise, and lifestyle changes required to achieve and
maintain healthy glycemic levels (i.e., within the range of
4.0–7.0 mmol/L).
In patient-centered education, self-management plans are
developed and maintained through collaboration between
patients, who raise their concerns, priorities, knowledge, and
resources, and the clinical expertise of health care professionals.
This deﬁnition of roles and responsibilities between patients and
health care professionals is claimed to increase the intrinsic
motivation of diabetic patients to persistently follow agreed plans
and attend medical checks [33–36]. This patient-centered
approach is part of a wider shift in health policy for long-term
care toward the “empowered patient” model in many countries,
and responds to rapidly rising diabetes-related health costs in
national health systems [37,38].
The didactic education model is very different. In the didactic
model, the patient is a passive recipient of standardized infor-
mation provided to all patients. The health care professional is an
expert who prescribes and deﬁnes good practice in diet, exercise,
and lifestyle choices. The passive patient is then expected to
adhere to the plans and prescriptions devised by the health care
expert [23,33].
Hence, it is important to evaluate the impact of different
education programs for diabetic patients. It has been proposed
that patient-centered education programs for type 2 diabetes are
more effective than didactic programs in changing behavior and
ensuring compliance [24–27,39]. Nevertheless, empirical evidence
on their beneﬁts is mixed [25,26,40] and different issues have
been raised in connection with previous trials. First, they do not
directly compare patient-centered and didactic programs. Rather,
control groups have consisted of patients receiving a mix of
alternatives, or no formal education at all [26,40]. There might be
selection bias because some trials include patients on medication
to control their HbA1c level. For these, reductions in recorded
HbA1c level may be due to teaching these patients how to take
their prescriptions rather than how to make improvements indiet, exercise, and lifestyle. Second, the reporting period is many
times too short. The literature ﬁnds [25] a difference of 0.92%
(P ¼ 0.01) in HbA1c level between groups 6 months after the
education program. This period, however, is generally considered
too short a period for permanent lifestyle changes to occur [40]
and it is commonly agreed that using a reporting period of 12 or
18 months is preferable. Third, there are important differences in
the patient-centered programs in the trials, and there is a lack of
consensus regarding the deﬁnition of patient-centered program,
its content, or its delivery [41].
Our trial study addressed all the aforementioned issues.
Furthermore, a novel contribution of our analysis is the applica-
tion of simultaneous quantile regression analysis. Previous
research on diabetes education has not considered whether
differential improvements in diabetes control vary across the
patient distribution. There are a priori reasons to expect differ-
entials to be nonmonotonic. At one end of the distribution are
patients who are healthy or close to the healthy glycemic range
when initially checked and diagnosed. These patients may only
need to make small lifestyle changes to improve their condition.
At the other end are patients with the worst health conditions
(including obesity). They face the biggest challenge in terms of
making sustainable, long-term changes to diet, exercise, and
lifestyle. Education programs, regardless of category, might not
have enough impact on these patients to make them reach the
healthy range. This article contributes to the literature by exam-
ining the relative impacts of alternative education programs
across the patient distribution.Methods
The Salford Trial
A total of 203 patients with type 2 diabetes were involved in the
Salford trial. The trial group received a patient-centered program
and the control group received a didactic education program.
Issues of patient self-selection and general practitioner (GP)
selection were dealt with. In Salford, all patients diagnosed with
type 2 diabetes are referred to a specialist education unit and
receive a formal education program within 1 month of diagnosis.
In the trial, patients were randomly selected to attend either the
didactic program or the patient-centered program. Of the 203
patients in the trial, 109 received the didactic program and 94 the
patient-centered program. Other issues were taken into account.
First, patients receiving medication to control their glycemic
levels received education but were excluded from the trial.
Second, all patients were drawn from the same set of six GP
surgeries conforming to the Salford Primary Care Trust to
guarantee homogeneity in patients—the city of Salford is a poor
socioeconomic area with high unemployment, poor housing and
social conditions, below national average education attainment,
and overwhelmingly white, British ethnic background. All the
same specialist education team delivered both programs in the
same number of sessions (three 2-hour sessions held over 3
consecutive weeks) free for patients, at a set of venues that were
local to patients within Salford.
In the didactic program, medical specialists stand in front of
the group and deliver the same presentation to all the patients
attending each session. The same information is provided to all
the patients who may raise questions. It is not tailored to
individual patients. The content of the didactic course provides
information on the causes of the condition and symptoms, on
diet and exercise, and on foot care. Besides the verbally provided
information, patients receive a set of leaﬂets available for free
from the National Health Service (NHS) and Diabetes UK.
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ing” approach based on learning sets applied to groups of 10 to 20
people. In such a program, health care professionals (trained in
a 2-day course) mediate discussions between patients on key
areas of diabetes health and self-management. It delivers basic
information so that patients can learn to use and critically
appraise information on diabetes. It shows patients how they
can translate this information to their own individual circum-
stances and helps them learn how best to interact with other
patients who face the same set of issues as themselves. Impor-
tantly, patients also learn how to frame questions and engage in
an open discourse with health care professionals mediating the
program. Consequently, patients gain conﬁdence in voicing their
concerns and interacting with health care professionals. This set
of skills and experiences is not developed in the didactic educa-
tion program. The patient-centered program is supported by an
“education pack” with the same basic information as in the
didactic program but its delivery is patient-centered, and patients
are made to reﬂect on their own present behavior and health
choices. The pack is divided into three sections, with session-
speciﬁc material designed to be read by patients before each
session. This initiates the process of patient self-reﬂection before
each of the relevant education sessions. Having read the support-
ing material, and having reﬂected upon it, patients use the
materials as the basis for discussion in their group sessions.
The patient-centered program ends with the drawing up of a
personal “action plan” with practical steps to change diet,
exercise, and lifestyle, and the key goals that they will strive to
achieve, supervised by the GP.
The difference in marginal costs between the two programs is
small and depends on two components. First, the cost of printed
materials provided to patients, which was £2.00 per pack for the
patient-centered program, whereas in the didactic program these
materials were provided free of charge to the Salford Diabetes
Education Team by the NHS and Diabetes UK. Second, the
patient-centered program included a 2-day training course for
the education team in the mediated learning approach that
underpins the patient-centered program. The opportunity cost
for the 2 days, based on the wages of the Salford Diabetes
Education Team, was £2,211.00 (the annual salary of the team
leader was £51,718 [NHS band 8B], the average salary of 10 nurses,Table 1 – Means, SDs, minimum and maximum values, 2
HbA1C scores and demographic variables Didactic grou
HbA1c_Month0 (mmol/L)
Mean  SD 7.749 1.629
Minimum 5.4
25th percentile 6.7
Median 7.4
75th percentile 8.5
Maximum 14.4
HbA1c_Month12 (mmol/L)
Mean  SD 7.163  1.00
Minimum 5.6
25th percentile 6.4
Median 6.8
75th percentile 7.9
Maximum 11.5
Age (y), mean  SD 65.35  8.45
Sex: female, mean  SD 0.54  0.5
White_eur, mean  SD 0.99  0.1
N 109
HbA1c, glycated hemoglobin A1c.dieticians, and podiatrists was £35,184 [NHS bands 6 and 7], and
the annual salary of the team administrator was £20,804). For the
94 patients attending the patient-centered education program,
the additional cost per patient was £26.00. It is important to note
that these marginal costs fall over time, as more patients receive
the patient-centered program, to the limit of £2.00 per patient
(i.e., the differential cost of printed materials) when we adopt
the perspective of the Salford Diabetes Education Team, or
to 0 when we consider the societal perspective (under which
we take into account that the NHS and Diabetes UK have
still to assume the cost of the printed materials for individuals
in the didactic program and that it was equally of £2.00
per pack).
Data Set
For each of the 203 patients, there were two fasting HbA1c scores
recorded by the patients’ GPs (406 observations). HbA1c_Month0 was
the fasting glucose level recorded when the patient was ﬁrst
diagnosed with type 2 diabetes. It indicated the patient’s diabetes
control before receiving one or other education intervention.
HbA1c_Month12 was recorded 12 months after diagnosis, as part
of the patient’s annual diabetes checkup. It indicated the
patient’s diabetes control 12 months after the education program.
The data set included three demographic variables that were
standard control variables: age of the patients at the time they
attended the education program, sex (indicated by the dummy
variable female), and ethnic background (indicated by the dummy
variable white_eur).
Table 1 provides descriptives for the variables in the data
set. There were no statistically signiﬁcant differences in sex,
age, or ethnicity of patients attending the two education
programs. Difference in mean female representation in the
patient-centered and didactic groups was 0.03 (54% and 57%
in the patient-centered and didactic groups, respectively). With
respect to age, the mean difference between the patient-centered
and didactic groups was the same (65.35  8.45 in the didactic
group and 65.8  9.69 in the patient-centered group). Regarding
ethnicity, the means and SDs for white European ethnicity were
identical because Salford residents are overwhelmingly white
European.5th percentile, median, and 75th percentile.
p Patient-centered group Pooled sample
7.759 1.621 7.754  1.621
5.5 5.4
6.6 6.6
7.3 7.3
8.7 8.6
14.1 14.4
9 6.838  0.859 7.012  0.954
5.3 5.3
6.3 6.4
6.6 6.7
7.5 7.7
9.3 11.5
65.35  9.69 65.35  9.05
0.57  0.49 0.55  0.49
0.99  0.1 0.99  0.1
94 203
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mean HbA1c_Month0 scores of patients in both programs was
nonsigniﬁcant: 7.759  1.621 mmol/L in the patient-centered
program and 7.749  1.629 mmol/L in the didactic program, with
t ¼ 0.0438 and 0.0439 for the two-sample t test with equal and
unequal variances, respectively (critical t0.05;203 ¼ 1.9718). After 12
months, however, there was a signiﬁcant difference of 0.325
mmol/L in the HbA1c_Month12 scores, which was lower for patients
attending the patient-centered program (at the 5% level): 6.838 
0.859 mmol/L in the patient-centered program and 7.163  1.009
mmol/L in the didactic program, with t ¼ 2.4479 and 2.4770 for
the two-sample t test with equal and unequal variances, respec-
tively (critical t0.05;203 ¼ 1.9718).
In terms of individual and social costs, the estimated mean
differences are highly important. The mean glycemic control of
the patient-centered education group was at the upper limit of
the healthy glycemic range in month 12 (6.838 mmol/L), whereas
for the didactic education group it was above that upper limit
(7.163 mmol/L). The median score was within the healthy range
in both groups although it was lower for the patient-centered
group than for the didactic group (6.6 and 6.8 mmol/L, respec-
tively). At the same time, the maximum value found in month 12
within patients in the patient-centered group was 9.3 mmol/LDidactic distribution HbA1c_Month0
Patient-centred distribution HbA1c_Month0
Note. N=203 (109 in the Didactic programme 
(A) (
(C) (
Fig. 1 – Quantile plots of initial HbA1c scores (in mmol/L) when re
after the program (HbA1c_Month12). HbA1c, glycated hemoglobin Acompared with 11.5 mmol/L in the didactic group, which meant
that patients with the worst conditions behaved better in the
patient-centered group than in the didactic group, although all of
them were still far from the healthy range.
We observed large differences in within-group changes
recorded in months 0 and 12. A reduction of 0.7 mmol/L was
recorded in median scores of the patient-centered group (month
12 ¼ 6.6 mmol/L; month 0 ¼ 7.3 mmol/L) and a reduction of
0.6 mmol/L was recorded in median scores of the didactic group
(month 12 ¼ 6.7 mmol/L; month 0 ¼ 7.4 mmol/L). This difference
increases in the distribution for patients with worse glycemic
control, being 1.2 and 0.6 mmol/L at the 75th percentile (month 12
¼ 7.5 mmol/L and month 0 ¼ 8.7 mmol/L for the patient-centered
group; month 12 ¼ 7.9 mmol/L and month 0 ¼ 8.5 mmol/L for the
didactic group) and 4.8 and 2.9 mmol/L at the maximum value or
for patients with the worst glycemic control (month 12 ¼ 9.3
mmol/L and month 0 ¼ 14.1 mmol/L for the patient-centered
group; month 12 ¼ 11.9 mmol/L and month 0 ¼ 14.4 mmol/L for
the didactic group). We also observed a notable difference in the
estimated mean scores. Subject to rounding errors, the mean
difference-in-difference improvement in glycemic control, over
12 months, for the average patient attending the patient-centered
program compared with the average patient attending theDidactic distribution HbA1c_Month12
Patient-centred distribution HbA1c_Month12
and 94 in the Patient-Centred programme).
B)
D)
ceiving an education program (HbA1c_Month0) and 12 months
1c. (Color version of ﬁgure available online).
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 3 5 3 – 3 6 2 357didactic program was 0.335 mmol/L (calculated as [7.759  6.838]
– [7.749  7.163]). Table 1 also offers the same statistics for the
pooled sample with patients attending both patient-centered and
didactic education programs, with N ¼ 203.
Figure 1 presents quantile plot graphs of the distributions of
HbA1c_Month0 and HbA1c_Month12 scores for both groups of patients
including the normal (Gaussian) distribution on the diagonal line.
These distributions are not right-skewed but have tails that lie
above the diagonal line. Therefore, the distribution matters for
the effect of education, and deviations from normality lie closer
to the center of the distribution.
Estimation Analysis
We applied the ordinary least squares (OLS) estimation strategy
with ﬁxed effects to test whether there was a statistical differ-
ence in the mean improvement in HbA1c level control (month 12
 month 0) of patients attending the patient-centered program
relative to those attending the didactic program (pc  didactic).
The estimated statistical model was:
Diff HbA1cið Þ¼β0þδ0pciþβ2olderthan65iþβ3femaleiþεi, ð1Þ
where the dependent variable Diff(HbA1c) is the total set of 203
observations, with the difference in the blood score at month
0 and the blood score taken at month 12 for each individual.
Our variable of interest is the dichotomous variable pci (patient-
centered program) that takes value 1 when the patient has
attended the patient-centered program and 0 if the patient has
attended the didactic program. Older than 65 and female are
demographic variables, and ε is the white noise error term.
A key issue not explored in previous research in diabetes
education studies is whether the impact of different education
programs varies across the patient distribution. We estimated, as
a robustness check, an OLS model containing a set of dummy
variables (Equation 2) with coefﬁcients for different ranges
depending on the initial glycemic level [IG(1)i ¼ 1 at the healthy
range when blood score at month 0 was lower than 7 mmol/L; IG
(2)i ¼ 1 when it was high but close to the healthy range when
blood score was between 7 and 8.5 mmol/L; IG(3)i ¼ 1 at very high
initial glycemic level when it was between 8.5 and 10 mmol/L;
and IG(4)i ¼ 1 at extreme initial glycemic level when blood score
was greater than 10 mmol/L at month 0]. In this estimation, we
were interested in the coefﬁcients (δ) for the interactions between
patient-centered program and the initial glycemic levels.
Diff HbA1cið Þ¼
X4
j¼1
αjIG j
 
iþ
X4
j¼1
δj pci  IG j
 
i
 þβ2olderthan65i
þβ3femaleiþεi, ð2Þ
Applying simultaneous quantile regression methods, one can
consider the differential impact on diabetes control in the
patient-centered program at individual points over the condi-
tional patient distribution.
Quantile methods are appropriate where distributions are
non-Gaussian or, as here, where there is heterogeneity between
segments of the analyzed conditional distribution [42]. Quantile
regression is a semiparametric method. The conditional quantile
has a linear form but does not impose a set of assumptions
regarding the conditional distribution, and minimizes the
weighted absolute deviations to estimate conditional quantile
(percentile) functions [43,44]. For the median (0.5 percentile),
symmetric weights are used. For all other percentiles (e.g., 0.1,
0.2, …, 0.9), asymmetric weights are used. In contrast, classical
OLS regression minimizes the sums of squared residuals to
estimate models for conditional mean functions.
Quantile regression is preferable to the alternative of seg-
menting the dependent variable into subsets according to its
unconditional distribution and then applying OLS on the subsetsbecause such truncation of the dependent variable can create
biased parameter estimates [45]. Because quantile regression
uses the full data set, the sample selection problem does not
arise. We dealt with the issue of heteroskedacity in standard
errors using Gould’s bootstrapping procedure [46,47]. Standard
errors were obtained via 1000 replications of a panel bootstrap.
This was drawn using a ﬁxed initial seed (i.e., 1000), with each
individual bootstrapped sample containing the same number of
observations as the original sample (i.e., 109 for the didactic
sample and 94 for the patient-centered sample). The software
used in all our estimations was Stata version 12 (StataCorp,
College Station, TX).Results
Table 2 presents the estimated coefﬁcients for our ﬁrst model.
The constant being negative and signiﬁcant (constant ¼ 0.709;
P ¼ 0.001), the effect of any type of education is, on average,
positive with a fall in HbA1c scores indicating improved glycemic
control 12 months after receiving education. Notably, the esti-
mated OLS coefﬁcient is 0.338 mmol/L (P ¼ 0.076), indicating
that, on average, patients attending the patient-centered pro-
gram better control their diabetes after receiving their program
than does the control patient group receiving a didactic education
program.
Table 2 also provides information on estimated simultaneous
quantile regression models at the 25th, 50th, and 70th percen-
tiles. In these estimated models, the estimated coefﬁcient is
negative but is signiﬁcant only for the 50th and 70th percentiles
[0.299 mmol/L (P ¼ 0.041) and 0.199 mmol/L (P ¼ 0.077),
respectively]. This indicates that net gains are nonmonotonic.
Age and sex tend not to be statistically signiﬁcant in the
estimated OLS and quantile models in Table 2. This is in line with
previous random control trials. To investigate this further, we
estimated an OLS model that contained a set of dummy variables
for different ranges of initial glycemic level (healthy, high but
close to healthy, very high, and extreme). In this way, one could
take into account the initial condition of patients when entering
one or other education program. We estimated the different
effects of patient-centered versus didactic education programs
for each range, through the interaction of these dummies and
their attendance of one or other program. Estimates are provided
in Table 3. For individuals within the healthy range, the intercept
is not signiﬁcant, but the patient-centered program is shown to
be signiﬁcantly more beneﬁcial than the didactic program, with a
coefﬁcient of 0.572 (P ¼ 0.014). For all other ranges of initial
glycemic control, with HbA1c level greater than 7 mmol/L (high,
very high, and extreme), the intercept is negative, statistically
signiﬁcant, and increasing (0.495 with P ¼ 0.004; 1.293 with
P ¼ 0.000; and 3.643 with P ¼ 0.000).
These results also indicate that education is increasingly
beneﬁcial at the initial HbA1c level (in mmol/L), whereas net
difference in the glycemic control of patients receiving a patient-
centered education relative to those receiving a didactic program
is nonmonotonic and depends on their initial condition. For
individuals with high initial HbA1c level but close to the healthy
range (7–8.5 mmol/L), both programs are equally effective (i.e., the
estimated coefﬁcient is not statistically signiﬁcant). Nevertheless,
for individuals with a very high initial HbA1c level (between 8.5
and 10 mmol/L), the patient-centered program is more effective
than the didactic program in improving the glycemic control,
with a coefﬁcient of 0.490 (P ¼ 0.083). Finally, for individuals
with an extreme initial HbA1c level (410 mmol/L) also, there is no
statistical difference in the glycemic control of patients receiving
either program.
Table 2 – OLS and quantile regressions on the difference between HbA1c scores of patients attending the
patient-centered program and the control group attending the didactic program.
Explanatory
variable
OLS 25th percentile 50th percentile 70th percentile
Coefﬁcient Robust
SE
Coefﬁcient Robust
SE
Coefﬁcient Robust
SE
Coefﬁcient Robust
SE
Patient-centered
program
(differential
impact relative
to didactic
program)
0.338* (0.189) 4.77  1007 (0.387) 0.299† (0.145) 0.199* (0.112)
Control variables
Female 0.157 (0.192) 0.500 (0.372) 0.299* (0.163) 1.09  1019 (0.226)
Older than 65 y 0.052 (0.192) 0.200 (0.338) 0.199 (0.232) 7.42  1017 (0.161)
Constant 0.709‡ (0.207) 1.600‡ (0.356) 0.599‡ (0.873) 2.36  1016 (0.172)
N 203 203 203 203
F 1.18
R2 0.0185
Pseudo R2 0.0148 0.0180 0.0090
Note. Dependent variable: difference between the HbA1c blood scores (mmol/L) in month 0 and month 12. Quantile bootstrap replications
¼ 1000.
HbA1c, glycated hemoglobin A1c; OLS, ordinary least squares; SE, standard error.
* P o 0.10.
† P o 0.05.
‡ P o 0.01.
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(month 0  month 12) in blood scores for the patient-centered
program compared with the didactic program shown in Figure 2A,
with signiﬁcant differences at the healthy initial range and also at
the third range of very high initial HbA1c level. In the case of the
patient-centered program, the predicted difference is always neg-
ative (beneﬁcial), whereas for the didactic program it is not.
To understand the difference in effectiveness of both programs,
it is useful to look at the 35 individuals (8 in the patient-centeredTable 3 – OLS estimation of the effect of patient-centered
variation of HbA1c blood scores by IG.
Explanatory variable
Constant by range of IG
IG(1): initial HbA1c o 7 mmol/L
IG(2): 7.0 mmol/L r initial HbA1c o 8.5 mmol/L
IG(3): 8.5 mmol/L r initial HbA1c o 10 mmol/L
IG(4): initial HbA1c Z 10 mmol/L
Differential effect (patient-centered relative to didactic program)
IG(1)  patient-centered
IG(2)  patient-centered
IG(3)  patient-centered
IG(4)  patient-centered
Demographic variables
Older than 65 y
Female
N
R2
Note. Dependent variable: difference (month 0 – month 12) in the HbA1c
HbA1c, glycated hemoglobin A1c; IG, initial glycemic level; OLS, ordinary
* P o 0.01.
† P o 0.05.
‡ P o 0.10.program and 27 in the didactic program) for whom the program has
not produced any beneﬁt and their glycemic control has worsened
(Fig. 2B). For them, the average difference is 0.425 (patient-centered)
and 0.837 (didactic), and is signiﬁcant for those individuals at the
healthy initial range, and the only range of the initial HbA1c level in
which the conditions of the individuals at the patient-centered
program worsen more than those of individuals at the didactic
program is between 7 and 8.5 mmol/L. Once again, age and sex are
found to be statistically nonsigniﬁcant.program relative to the didactic program in the
Coefﬁcient SE P 4 |t|
0.182 0.231 0.430
0.495* 0.169 0.004
1.293* 0.195 0.000
3.643* 0.411 0.000
0.572† 0.231 0.014
0.053 0.180 0.769
0.490‡ 0.281 0.083
0.044 0.585 0.940
0.085 0.135 0.532
0.094 0.127 0.458
203
0.6847
blood scores (mmol/L).
least squares.
(A)
(B)
Fig. 2 – (A) Predicted difference in the blood score (in mmol/L) for
individuals receiving either the patient-centered program or the
didactic program. (B) Predicted difference in the blood score (in
mmol/L) for individuals worsening their glycemic control
(month 0month 12) at both the patient-centered program and
the didactic program. (Color version of ﬁgure available online).
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program, in patients achieving a healthy glycemic range after
12 months. The most signiﬁcant differences are for individuals at
the healthy initial level and for those with the initial glycemic
level between 8.5 and 10 mmol/L.
To explore more extensively the different effectiveness of both
programs across the distribution, a set of simultaneous quantile
regression models were estimated at 0.05 percentile intervals,
from the 0.05 to the 0.95 percentile. Table 5 presents the coef-
ﬁcients for the intercept and the patient-centered differentialTable 4 – Percentage of patients within the healthy
glycemic range by month 12, according to IG.
IG Patient-
centered (%)
Didactic
(%)
IG(1): initial HbA1c o 7 mmol/L 100.00 88.57
IG(2): 7.0 mmol/L o initial
HbA1c o 8.5 mmol/L
62.96 56.52
IG(3): 8.5 mmol/L o initial
HbA1c o 10 mmol/L
47.37 22.22
IG(4): initial HbA1c4 10 mmol/L 22.22 20.00
HbA1c, glycated hemoglobin A1c; IG, initial glycemic level.effect for such models (demographic variables were included but
not reported because they were mostly nonsigniﬁcant). Results are
consistent with our previous estimations. Nevertheless, it is
important to note that where in the OLS analysis we ascertained
the average improvement effects for individuals who started with
different glycemic control levels, with the quantile regression we
can examine the effects on the q quantile itself.
We observe a nonmonotonic relationship across the patient
distribution. In the ﬁrst half of the HbA1c distribution, the differ-
ence between blood scores at month 0 and month 12 is mostly
explained by the intercept, which is negative, large, and statisti-
cally signiﬁcant (percentiles 0.05–0.50). The differential effect of
the patient-centered program is negative but nonsigniﬁcant.
Progressing further along the distribution (percentiles 0.50–
0.90), the differential becomes larger and the effect of education
is more often explained by attendance of a speciﬁc program than
by the intercept (the receiving of education in general). This
indicates that there is a strong effect because of the patient-
centered program for patients within this range.
Figure 3 shows the coefﬁcients for the intercept and the
differential effect of the patient-centered program across the
distribution. We see that the net difference in glycemic control
is always negative and mostly signiﬁcant (95% conﬁdence inter-
val) between the 50th and the 90th percentiles of the distribution.
The difference, however, is nonmonotonic, decreasing in abso-
lute value between the 50th percentile (0.300; P ¼ 0.041) and the
70th percentile (0.200; P ¼ 0.077). Above the 70th percentile, the
differential increases up to the 90th percentile (0.400; P ¼ 0.042),
after which the estimated differential becomes nonsigniﬁcant for
the remainder of the HbA1c distribution.Conclusions
Education leads individuals to take better health-related deci-
sions and develop improved preventative behavior. Education is
thus an important component in preventative health policy,
especially for patients with chronic conditions such as diabetes.
In this article, we considered two categories of education pro-
grams designed to promote behavioral change to healthier life-
styles among people with type 2 diabetes, and thereby prevent or
reduce signiﬁcantly the severity of the complications associated
with this condition. In contrast with chronic obstructive pulmo-
nary disease, cardiac disease, asthma, and type 1 diabetes for
which there is strong evidence of a relationship between educa-
tion and improved health outcomes [20–22], empirical evidence
for type 2 diabetes is mixed [25,26,40].
The empirical results clearly indicate improvements in the
mean glycemic control of patients receiving the patient-centered
program after 12 months compared with patients receiving the
didactic program. On the basis of a well-speciﬁed control group,
the average effect estimated by OLS is 0.338 mmol/L, at the
upper end of previous trials reported in the meta-studies [26,40].
This level of improved metabolic control represents a signiﬁcant
reduction in complications and improvement in quality of life.
By also applying OLS at different ranges of the glycemic level
and quantile regression methods, the present study sheds new
light on the effectiveness of education programs. In particular, it
has identiﬁed four distinct categories of patients within the
diabetic population. On the basis of the ﬁndings of our study,
patients initially at the healthy range need to understand their
condition and undertake preventive measures to avoid future
complications. For them, patient-centered education is signiﬁ-
cantly more effective than the didactic program. In fact, the
didactic program is not effective for those patients because on
average they worsen their glycemic control. Hence, patients
initially at the healthy range should attend patient-centered
Table 5 – Estimates of the differential improvement in glycemic control of patients attending patient-centered
programs compared with those attending didactic programs, and intercept in the simultaneous quantile
regressions (distribution 5%–95%).
Percentile Differential (patient-centered relative to didactic program) Intercept
Coefﬁcient SE P 4 |t| Coefﬁcient SE P 4 |t|
0.05 –1.300 0.922 0.160 –2.000* 0.977 0.042
0.1 –0.600 0.575 0.298 –1.900† 0.572 0.001
0.15 –0.300 0.488 0.539 –1.900† 0.406 0.000
0.2 0.000 0.454 1.000 –1.700† 0.380 0.000
0.25 0.000 0.388 1.000 –1.600† 0.357 0.000
0.3 –0.100 0.300 0.740 –1.300† 0.333 0.000
0.35 –0.200 0.228 0.381 –1.100† 0.295 0.000
0.4 –0.200 0.198 0.313 –0.800† 0.247 0.001
0.45 –0.200 0.177 0.261 –0.700† 0.184 0.000
0.5 –0.300* 0.145 0.041 –0.600† 0.142 0.000
0.55 –0.200 0.123 0.106 –0.500† 0.143 0.001
0.6 –0.300† 0.113 0.009 –0.400* 0.172 0.021
0.65 –0.200‡ 0.113 0.079 –0.200 0.189 0.290
0.7 –0.200‡ 0.112 0.077 0.000 0.173 1.000
0.75 –0.100 0.112 0.375 0.000 0.153 1.000
0.8 –0.200‡ 0.111 0.073 0.200 0.150 0.185
0.85 –0.300* 0.116 0.011 0.300‡ 0.156 0.056
0.9 –0.400* 0.195 0.042 0.500‡ 0.284 0.080
0.95 –0.800 0.685 0.244 1.000 0.811 0.219
SE, standard error.
* P o 0.05.
† P o 0.01.
‡ P o 0.10.
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 3 5 3 – 3 6 2360education. They should attend patient-centered education. Sec-
ond, patients with high glycemic levels but close to the healthy
range are able to make changes in their lifestyles within 12
months. For them, any education program is effective andDependent variable: difference in HbA1
Fig. 3 – Percentile distribution of the intercept and differential im
in simultaneous quantile regressions [dependent variable: diffe
glycated hemoglobin A1c.beneﬁcial compared with the alternative of no education.
Although results are better for the patient-centered program,
the difference is not signiﬁcant, probably because being close to
the healthy range, but already unhealthy, patients enrolled inc blood scores (Month 0 – Month 12).
pact of the patient-centered relative to the didactic program
rence in HbA1c blood scores (month 0  month 12)]. HbA1c,
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 3 5 3 – 3 6 2 361any program obtain a high rate of success. Third, patients with
very high glycemic levels need speciﬁc education to contribute to
their behavioral change. Being far from the healthy glycemic
level, engaging patients becomes more important and our ﬁnd-
ings suggest that for this category of patients, again, patient-
centered education is more effective than didactic education.
Finally, for patients with the worst health conditions, including
obesity, and, as a consequence, the highest individual health
costs, we ﬁnd that patients receiving patient-centered education
do not beneﬁt more than do patients receiving didactic educa-
tion. For this category of patients, aware of their need, both
patient-centered and didactic preventative education programs
are very effective in changing lifestyles and improving health
choices, and all of them improve their glycemic control even if
most of them do not get to the healthy range in 12 months.
Our research ﬁndings highlight the need for a stratiﬁed health
policy. Preventative health policy can be effective for most
patients at initially healthy, high, or very high glycemic level,
and the patient-centered program presents better results. Our
results present several limitations. First, they are based on our
case study with a sample size of 203 individuals. As a conse-
quence, to generalize our results and policy recommendations for
education programs, they should be conﬁrmed by similar studies.
Also, the focus in our article was not to do a full cost-
effectiveness analysis of the two education programs. Never-
theless, previous work on the economic evaluation of diabetes
education programs [48], literature relating improvement in the
control of glycemic levels and a lower demand of health services
and expenditures [29–32], and the minimum additional cost per
patient (£26.00) of the patient-centered program point to signiﬁ-
cant savings in health expenditures for patients in the relatively
healthy and intermediate categories at the initial diagnosis.
Nevertheless, for the last patient category—made up of patients
with the most severe condition—education is effective in improving
glycemic control but not in getting patients into the healthy range,
and guidelines are required for ﬁnding their most effective treat-
ment or complement to education. This may include alternative
interventions such as bariatric surgical procedures (gastric banding,
gastric bypass, or sleeve gastrectomy). The cost-beneﬁt implications
for health expenditure of surgical procedures such as these are
different from those of preventative health education programs.
Although further research is needed on this topic, our results point
to policy stratiﬁcation as a requirement to achieve an optimal
resource allocation, which produces the correct mix of education
and other health interventions for different patient categories.Acknowledgments
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